Although the tricarboxylic acid (TCA) cycle is the prime means of carbon metabolism for energy generation in normal myocardium, the noninvasive quantification of TCA cycle flux in intact cardiac tissues is difficult. A novel approach for estimating citric acid cycle flux using`3C nuclear magnetic resonance (NMR) is presented and evaluated experimentally by comparison with measured myocardial oxygen consumption over a wide range of cardiac contractile function in intact, beating rat hearts. Continuous series of`3C NMR spectra, obtained after the introduction of [2-`3C acetate as substrate, quantified the time course of 13C appearance in the
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Intact Hearts by Carbon-13 Nuclear Magnetic Resonance Robert G. Weiss, Sean T. Gloth, Roberto Kalil-Filho, Vadappuram P. Chacko, Michael D. Stern, and Gary Gerstenblith Although the tricarboxylic acid (TCA) cycle is the prime means of carbon metabolism for energy generation in normal myocardium, the noninvasive quantification of TCA cycle flux in intact cardiac tissues is difficult. A novel approach for estimating citric acid cycle flux using`3C nuclear magnetic resonance (NMR) is presented and evaluated experimentally by comparison with measured myocardial oxygen consumption over a wide range of cardiac contractile function in intact, beating rat hearts. Continuous series of`3C NMR spectra, obtained after the introduction of [2-`3C acetate as substrate, quantified the time course of 13C appearance in the carbon positions of myocardial glutamate, which are sequentially enriched via citric acid cycle metabolism. A TCA cycle flux parameter was calculated using the premise that TCA cycle flux is inversely proportional to the time difference between 13C appearance in the C-4 and C-2 positions of glutamate (glutamate Atso [minutes] ), which are enriched in subsequent "turns" of the TCA cycle. This TCA cycle flux parameter, termed KT, correlated strongly with myocardial oxygen consumption over a range of developed pressures in hearts perfused with 5 mM acetate (r=0.98, p<0.001), as well as in separate studies in hearts perfused with 5 mM glucose and 0.5-0.8 mM acetate (r=0.94,p<0.001). Results of numerical modeling of 13C glutamate kinetics suggest that this TCA cycle flux parameter, KT, is relatively insensitive to changes in metabolite pool sizes that could occur during metabolism of other substrates or during conditions of altered oxygen availability. Additional studies in separate hearts indicated that the time course of`C appearance in citrate, which is predominantly mitochondrial in the rat heart, is similar to that in glutamate, further supporting the premise that the described`3C NMR parameters reflect mitochondrial citric acid cycle activity in intact cardiac tissues. (Circulation Research 1992;70:392-408) diac tissues and mitochondrial preparations are typically based on measurements of oxygen consumption, uptake or liberation of radiolabeled tracers, and changes in TCA cycle intermediate pool sizes,1-6 many of which are not well suited to studies in intact systems. Another strategy is the use of`3C nuclear magnetic resonance (NMR) spectroscopy with 13Cenriched substrates. Together they can be exploited to repetitively and nondestructively quantify the time course of the appearance of labeled carbon nuclei within intracellular metabolite pools in intact organs, animals, or humans. Such an approach has been used with a mathematical simulation of the TCA cycle to calculate absolute steady-state TCA cycle flux from data obtained from rat hearts. 7 The results generated by that model were not, however, rigorously compared with other measures of TCA cycle flux over a range of values, such as might be induced by varied physiological contractile conditions. In addition, utilization of the model requires advanced computing facilities and quantification of all TCA cycle intermediate pool sizes; the latter requires tissue extraction and thereby precludes repetitive studies in a given tissue or truly in vivo studies. The recent development of spatially localized`C NMR spectroscopic techniques for human heart studies8 underscores the potential importance of "C NMR utilization to nondestructively quantify cardiac TCA cycle activity.
The purpose of the current work was to test the hypothesis that "C NMR parameters alone can be used to index TCA cycle flux noninvasively in intact hearts. The experimental approach was to derive "C NMR indexes of TCA cycle flux from the time course of 13C appearance in intracellular metabolite pools of intact beating rat hearts and compare them with measured myocardial oxygen consumption across a range of contractile performance since oxygen consumption is critically linked to TCA cycle flux. The general validity of this method was assessed by studying two different substrate conditions and also by separate mathematical modeling analysis of intermediate pool size conditions beyond those expected for the experimental conditions. Because TCA cycle activity occurs in mitochondria, additional experiments were performed to compare the time course of "3C appearance in mitochondrial intermediates with metabolites predominantly occurring in the cytosol.
Materials and Methods Isolated Rat Heart Nonfasting, ex-breeder, male Wistar rats were anesthetized with 100-150 mg intraperitoneal pentobarbital. After rapid excision of the heart, the aorta was cannulated for retrograde constant-flow perfusion at 15 or 20 ml/min via a peristaltic pump with oxygenated solution at 37°C. The perfusate was pumped through small-diameter tubing to minimize mixing effects during changes in perfusate constituents. The perfusate contained (mM) sodium 144, potassium 5, calcium 1.5, HEPES 6, magnesium 0.9, inorganic phosphate 1, chloride 152, and acetate 5, as well as lidocaine 5 gg/ml. The pH was adjusted to 7.4. Preliminary experiments performed with bicarbonate buffer demonstrated results similar to those performed with HEPES buffer. Perfusate was not recirculated. Hearts were paced at either 140 or 220 beats per minute by using an SD-9 stimulator (Grass Instrument Co., Quincy, Mass.) via a KCI wick electrode placed into the right ventricle. A polyvinyl chloride balloon attached to polyethylene (PE-190) tubing was inserted into the left ventricle through the mitral valve. The balloon was filled in increments to obtain the maximum isovolumic developed pressure during systole, which usually occurred at an end-diastolic pressure of 10-16 mm Hg. The balloon solution contained [6-"C]hexanoic acid and phenylphosphonic acid (at pH 7.0), which served as "C and 31P NMR standards. The other end of the polyethylene tubing was connected to a Gould P23Db transducer for continuous measurements of left ventricular pressure. [ 
Nuclear Magnetic Resonance Spectroscopy
The hearts were positioned in a remotely switched dual-tuned ("C and "P) 20-mm commercial probe of a Bruker AM 360-WB NMR spectrometer (field strength, 8.5 T). Magnetic field homogeneity was optimized while observing the water proton signal with the decoupler coil. Proton-decoupled, minimally saturated 31P spectra were obtained with a 2.1-second delay between pulses of 22-,usec duration (600) by using a 2,000 -point data table, and proton-decoupled 13C spectra were collected with a 1.1-second delay between pulses of 22-,usec duration (600) using 2,000 points and zero-filled to 8,000. Free induction decays were Fourier transformed, and a line broadening of 15-20 Hz was introduced. Intracellular pH was measured by the chemical shift of the inorganic phosphate peak relative to the creatine phosphate (PCr) peak.9 Peak areas were measured by integrating areas under individual peaks by hand digitization (SIGMASCAN, Jandel Scientific, Corte Madera, Calif.).
Before introduction of a 13C-enriched substrate in the perfusate, a calibration graph for the determination of absolute metabolite concentrations was constructed for each heart. The intraventricular balloon volume was incremented, in steps, with solution containing known concentrations of phenylphosphonic and [6-1"C]hexanoic acids. After each increment, 31p or 13C NMR spectra were acquired. Each increment in balloon volume placed precise, known amounts of 31P and 13C compounds within the sensitive volume of the NMR coil. These acquisitions also provided natural abundant 13C spectra from the tissue and perfusate. Integrated peak areas of 13C spectra were determined from difference spectra between these natural abundance and enriched acquisitions. The areas of all peaks were corrected for partial saturation and nuclear Overhauser enhancement by comparison with fully relaxed spectra without nuclear Overhauser enhancement,10'11 and integrated peak areas of heart metabolites were converted to absolute concentrations by comparison with the peak areas of the 13Cor "P-containing substance within the intraventricular balloon, which acted as a standard. Hearts were weighed at the beginning of the experiments, and results are expressed as micromoles of metabolite per gram wet weight. Wet-to-dry weight ratios measured under comparable conditions in glucose-perfused rat hearts range from 6.5 to 7.0.12
The quantity of each "C metabolite was plotted versus time after introduction of "C-enriched sub- is inversely proportional to flux through tions 2-10 or one turn ("lap") of the TCA cycle. ther words, we hypothesize that TCA cycle flux ilations can be based on the premise that the 13C ,arances in isotopomers of TCA cycle-derived bolic intermediates can serve as "lap counters" 3C TCA cycle flux. cause of the inherent limited sensitivity of NMR troscopic detection, it is not possible to directly c the movement of each 13C nucleus through bolic pathways. Rather, one can measure the course of 13C enrichment in intermediate pools, as glutamate. Determination of the time of il 13C enrichment of each glutamate isotopomer mewhat imprecise. One approach would be to fit Lisotopomer enrichment curve and extrapolate to )oint in time where the enrichment was last equal ro. A more precise approach is to measure the to half-maximal enrichment, t50.7 Thus the glute At50, the difference between the t50 of gluta-C- 4 and that of glutamate C-2 (or C-3), rectly proportional to the time for a 13C "lap" in simplified convention and therefore inversely proportional to`3C-labeled flux. This time is dependent not only on TCA cycle activity, however, but also on the sum total of the TCA cycle intermediate pool sizes and the pools of amino acids (glutamate and aspartate) in rapid equilibrium with cycle intermediates since for any given flux the larger the pools the longer it will take for label to move through the cycle. A parameter, KL (micromoles of`3C per minute per gram of tissue), can therefore be defined that relates directly to`3C-labeled flux through the TCA cycle [ITCA cycle-derived metabolites (/Lmol/g)] glutamate lAt50 (min) where ITCA cycle-derived metabolites is the sum of the This parameter is directly proportional, but not necessarily equal, to total TCA cycle flux. This approach to TCA cycle flux calculation is based on the time difference between the appearance of tracer in various positions of the same TCA cycle-derived metabolite and is, therefore, independent of substrate-tracer input considerations. For instance, differences in isotope delivery to organs or in cellular uptake would alter equally both the t50 for glutamate C-4 and the t50 for glutamate C-2 but not affect the glutamate At50.
The assumptions in this method include 1)`3C entry into the TCA cycle from [2-'3C]acetate is via acetyl-CoA, 16 2)`3C NMR accurately quantifies 13C enrichment of the noncarbonyl carbons of the glutamate isotopomers (see "Results"), 3) glutamate and TCA cycle intermediate pool sizes are not changing during 13C infusion under steady-state conditions, 4) the metabolism of '3C substrates is the same as that of 12C substrates, and 5) exchange of intermediates between mitochondrial and cytosolic compartments is rapid (see "Results").
[E13C NMR-detected TCA metabolites (gmol/g)] glutamate 1At50 (min) For anaerobic hearts'3 or normoxic hearts using other substrates including exogenous odd-numbered fatty acids,14 the numerator may also include additional terms for citrate, succinate, and possibly malate, if these are present in adequate concentrations to permit NMR detection. The concentration of the 13C glutamate pool is determined from the C-4 isotopomer since it is fed directly by acetyl-CoA and is not influenced by anaplerotic contributions. The concentrations of the 13C-enriched aspartate and citrate pools are determined from the C-3 (or C-2 for aspartate) isotopomers and require correction for unlabeled anaplerotic flux.14 The total TCA cycle flux is the sum of the '3Clabeled flux and the unlabeled 12C flux, the latter commonly arising from endogenous triglycerides and glycogen. The relative contributions of the labeled and unlabeled flux can be calculated with the knowledge of the fraction of total acetyl-CoA (FEa) entering the TCA cycle that is 13C enriched. This proportion can be calculated by analysis of the 13C-'3C spin-spin splitting pattern of the glutamate C-4 resonance and the steady-state glutamate C-2/C-4 ratio after correction for nuclear Overhauser enhance-
Numerical Model of Tricarboxylic Acid Cycle Kinetics
Because a vast number of substrate combinations could occur physiologically and could not all be reasonably evaluated experimentally, a mathematical model was developed to help assess the general validity of the proposed analytic method. This mathematical model was also used to assess the potential impact of different intermediate pool sizes, which might be induced by changes in substrate availability or oxygen delivery, on the glutamate A1t50 and calculated KT. These were calculated because differences in intermediate pool sizes, independent of any changes in citric acid cycle activity, may influence the time course of glutamate l3C enrichment. The model itself is presented in the "Appendix," and the findings from the model that are pertinent for interpreting the potential impact of differences in intermediate pool sizes on glutamate At50 and KT are presented in "Results."
Myocardial Oxygen Consumption
The oxygen tension of perfusate sampled from the aortic inflow and from the coronary effluent of the right ventricle was measured with a blood gas ana- 
Tissue Extracts Some hearts underwent tissue extraction. These hearts were frozen by rapid compression between tongs cooled to the temperature of liquid nitrogen. The frozen tissue was pulverized in a mortar under liquid nitrogen in 6% perchloric acid and centrifuged for 10 minutes at 5,000g. The supernatant was reneutralized with 2 M potassium hydroxide and centrifuged again. Hearts undergoing amino acid analysis by high-performance liquid chromotography (HPLC) had 0.73 mM tyramine added as an internal standard before centrifugation. Amino acid concentrations were evaluated by gradient elution on a 150x 4.6 mm i.d. analytic column packed with 5-,umdiameter Excellopak ODS with quantitative fluorometric elute analysis. The peak ratios of glutamate, aspartate, and internal tyramine standard were compared as previously described. 19, 20 Protocols 3C nuclear magnetic resonance estimates of tricarboxylic acid cycle flux. First principles suggest that myocardial oxygen consumption rates parallel those of net carbon movement through the TCA cycle and therefore valid indexes of TCA cycle flux should correlate with myocardial oxygen consumption over a wide range. Two sets of independent experiments were performed to test whether these proposed 13C NMR estimates of TCA cycle flux correlate with measured myocardial oxygen consumption over a wide range of contractile performance. Because of concerns about the reliability of myocardial oxygen consumption measurements obtained from hearts within a magnet by sampling effluent outside the magnet through nonmagnetic, oxygen-permeable tubing,21 myocardial oxygen consumption was quantified in parallel experiments in separate hearts under contractile conditions identical to those in the magnet in the first series of experiments. In a second series of experiments, myocardial oxygen consumption was measured in the same hearts studied by`C NMR on removal from the magnet at the end of each experiment. So that the results were not limited to a single set of experimental conditions, the substrates used and the manner in which developed pressure was varied also differed in these two series of experiments. All hearts were initially perfused with solution containing 1.5 mM Ca21 while 31P and`C standard calibration data were acquired. Each heart was subsequently studied with "3C NMR at a single developed pressure as described below. Because prior work had shown that pool sizes of various TCA cycle intermediates may change and that flux through different spans of the TCA cycle may be transiently unequal2,22,23 immediately after acute changes in work load or substrates, each heart was stabilized at the new developed pressure with unlabeled substrates for 12-15 minutes after the baseline period to ensure that a new steady state was reached before [2-1'C]acetate introduction.2 Thus,`C enrichment occurred when pool sizes were stable.
In the first series of experiments (n=16), hearts were paced at 140 beats per minute, and the perfusion rate was 15 ml/min. The perfusate contained 1 mM inorganic phosphate and the sole substrate was 5 mM acetate. Each heart was studied at one of four contractilities, determined by changing perfusate calcium concentration. These were perfusion with 1.5 mM Ca21 (n=6), 0.8 mM Ca24 (n=3), 0.5 mM Ca24 (n=4), or 1.5 mM Ca24 and 20 mM K' (n=3). Myocardial oxygen consumption was measured in separate hearts under identical conditions and at matched developed pressures.
In the second series of experiments (n=8), hearts were paced at 220 beats per minute, and the perfusion rate was increased to 20 ml/min. Inorganic phosphate was omitted from the perfusate, and the substrates were unlabeled 5 mM glucose and 0. 
cially available software (SIGMAPLOT, Jandel Scientific, and SYSTAT, SYSTAT, Inc., Evanston, Ill.).
Results

Estimates of Trticarboxylic Acid Cycle Flux by 13C Nuclear Magnetic Resonance
Hearts perfused with 5 mM acetate alone. Mean left ventricular developed pressure (developed pressure= systolic-end-diastolic pressure) in all 16 hearts studied with NMR spectroscopy during the initial high developed pressure period was 142±+8 mm Hg. A representative 31P NMR spectrum acquired during this initial period is shown in Figure 2 , and analysis of the peak areas reveals high levels of PCr and ATP. Most of the inorganic phosphate peak (chemical shift, 5.35 ppm relative to PCr) arises from 1 mM phosphate contained in the perfusate (pH 7.4) and relatively little from intracellular phosphate (chemical shift, 4 .95 relative to PCr). No attempt was made to quantitatively distinguish these forms of inorganic phosphate. The initial mean PCr level was 7.5+0.6 gumol/g wet wt, ATP level was 3.2±0.3 ,gmol/g wet wt (from the f3 phosphorus of ATP), and intracellular pH was 7.22±0.02. These are similar to previously published values for perfused rat hearts.29-31 Both high contractile function and normal levels of high energy phosphates suggest that perfusion was adequate at this high initial contractility.
Developed pressures varied over a wide range for the four subsequent contractile conditions and were comparable for hearts studied for oxygen consumption and with NMR spectroscopy at each perfusate calcium concentration: 133± 14 versus 138±3 mm Hg at 1.5 mM Ca2t, 80±3 versus 80±1 at 0.8 mM Ca2+t 37+9 versus 42±4 at 0.5 mM Ca2+, and 0 versus 0 for K'-arrested hearts (p=NS for each). The closely matched contractile indexes ( Table 1 ) strongly suggest that metabolic flux rates were similar in these parallel experiments. Oxygen consumption increased with contractile performance and was 1.36+±0.11 gmol/ min/g wet wt in Kt-arrested hearts and 1.92±0.22, 2.86±0.37, and 3.68±0.35 ,umol/min/g wet wt at perfusate Ca2t concentrations of 0.5, 0.8, and 1.5 mM, respectively ( Table 1 ). This range of oxygen consumption values closely agrees with those previously reported for rat hearts under comparable conditions.32 Figure 3 presents a representative`3C NMR difference spectrum obtained from an intact heart 30 minutes after the substitution of [2-13C]acetate for the nonenriched form. This spectrum was acquired during approximately 5 minutes (280 acquisitions) by using 600 pulses with a 1.1-second interpulse delay and shows the prominent peaks of the glutamate isotopomers (C-2, C-4, and C-3; peaks A, D, and E, respectively), the [2-1'3C]acetate substrate (peak F), and the [6-1'3C]hexanoic acid contained within the intraventricular balloon (peak H). In addition, smaller resonances attributed to aspartate (C-2 and C-3; peaks B and C) and acetylcarnitine (C-2; peak G) can be identified, as previously described.7,3334 Citrate resonances are usually not identified in hearts perfused with acetate alone. Figure 4 shows the time course of 13C enrichment of the glutamate isotopomers from a representative heart perfused with 1.5 mM Ca2t (upper panel) and that of another heart perfused with 20 mM K' (lower panel). The effect of reduced contractile function is to delay the time course of glutamate enrichment and to increase the time difference between the enrichment of the C-4 and C-2 glutamate isotopomers.
Note that the glutamate tAt50, the difference between t50 for glutamate C-4 and glutamate C-2 denoted by the width of the shaded region, is markedly prolonged at the lower contractile performance, indicat- The different plateau values of glutamate C-4 and C-2 are due to a small amount of anaplerotic flux (e.g., the addition of unlabeled carbons to the total TCA cycle carbon pool via a mechanism other than the citrate synthase reaction). The relative anaplerotic to acetyl-CoA-derived flux was 8% for all of these hearts and agrees with previously measured values in acetate-perfused hearts.14 '15 Total TCA cycle flux can be derived from the 13C-labeled flux by calculation of FEa, the fraction of acetyl-CoA entering the TCA cycle that is '3C enriched (see Equation 4 ). The 13C-'3C spin-spin splitting pattern of the glutamate C-4 resonance was similar in spectra of intact hearts and of their perchloric acid extracts (not shown), and therefore intact heart data were used. FEa was largely unchanged over the contractile performance range studied with a mean for all hearts of 92±2% (see Table 1 ). This is in close agreement with previously published values of 88-97% for acetate-perfused hearts.1415 Thus, during perfusion with [2-13C]acetate as sole substrate, labeled flux accounts for most of the total TCA cycle flux, and KL nearly equals KT. Table 1 compiles the results of contractile function, oxygen consumption, 13C NMR data, and calculated TCA cycle flux parameters for all hearts studied. In summary, increased contractile performance resulted in graded increases in oxygen consumption and decreases in glutamate At50. The calculated total TCA cycle flux constant, KT, increased from 0.39±0.04 to 1.27±0.15 gmol/min/g wet wt over the developed pressures studied and parallels the increase in oxygen consumption from 1.36±0.11 to 3.68±0.35 gumol/min/g wet wt.
Because a linear relation between developed pressure and oxygen consumption has previously been recognized in the isolated Langendorff-perfused rat heart,17 this relation was also analyzed in these hearts ( Figure 5 ). The oxygen consumption/developed pressure (upper panel) and the KT/developed pressure (lower panel) relations are presented in Figure 5 . Both oxygen consumption [MVo2=0.0176(DP) +1.305; r=0.87, p<0.01] and KT [KT=0.00583(DP)+0.439; r=0.89, p<0.01] correlate fairly well with developed pressure (DP in equations). Note that the x axis intercept represents the basal metabolic oxygen consumption (upper panel) or basal TCA cycle flux parameter (lower panel). Previous work has shown that definitions of cardiac work other than developed pressure alone, and specifically those that include contractility, more closely correlate with myocardial oxygen consumption than does developed pressure or rate/pressure product alone. 36 Therefore, the comparable scatter in the oxygen consumption/developed pressure and KT/developed pressure relations is likely accounted for, at least in part, by differences in contractility of these separate hearts.
Total TCA cycle flux is expected to best correlate with myocardial oxygen consumption. Figure 6 presents the relation between the calculated TCA cycle flux constant, KT, and oxygen consumption for the parallel experiments of hearts studied at these four levels of contractile function and shows a strong linear correlation between myocardial oxygen con- zero and predicts the anticipated relation that oxygen consumption ceases when TCA cycle flux is halted.
Hearts perfused with both glucose and acetate. The baseline mean developed pressure for the eight hearts studied during glucose and acetate perfusion was 184±7 mm Hg and the mean end-diastolic pressure was 3 ± 1 mm Hg. A representative 31P NMR spectrum is shown in Figure 7 and evidences, as in the earlier series, high levels of high energy phosphates. Note that inorganic phosphate was not present in the buffer in these experiments and therefore the small peak at approximately 5.0 ppm, relative to PCr, represents intracellular inorganic phosphate. A phosphonate standard was not used in several of these hearts, so absolute high energy phosphate levels could not be determined. However, the mean PCr/ATP ratio in these hearts was 1.9+0.1 and the mean intracellular pH, 7.19+0 .01. Figure 8 shows a`3 C NMR spectrum also obtained from a heart during perfusion with unlabeled 5 mM glucose and 0.8 mM [2-13C]acetate.
The mean steady-state "3C pool size of glutamate C-4 was 3.5 +0.3 ,umol/g wet wt and that of aspartate C-3, 0.9+±0.2 ,umol/g wet wt. The mean contribution of anaplerotic relative to acetyl-CoA-derived flux was only 6+1%. The calculated mean fraction of acetyl-CoA derived from [2-13C] acetate was 91±2%, which did not differ from that measured in the hearts perfused by acetate alone. This is likely due to inactivation of pyruvate dehydrogenase by even relatively low concentrations of mediumand shortchain fatty acids, including acetate, which has been reported previously.10,35 Figure 9 presents the relation between myocardial oxygen consumption and the TCA cycle flux parameter, KT, measured in each of these eight hearts. Note that under these conditions, with the higher pacing rate, a considerably wider range of flux rates is attained than in the earlier experiments (see Figure 6 ). Despite differences in experimental conditions, KT correlates strongly with myocardial oxygen consumption over a wide range [KT=0.477(MVO2)-0.245; r=0.94, p<O.OOl] in these hearts as well. Analysis of covariance indicated that there was no significant difference between this MV02/KT relation (Figure 9 ) and that observed in the first series of experiments ( Figure 6 ). It is important to note that under two separate experimental conditions that differ in substrate availability, heart rate, coronary flow, ionic milieu, and the manner in which contractile function was varied the 13C NMR parameter KT, which we have proposed to index total TCA cycle flux, correlates strongly with myocardial oxygen consumption across a wide range.
Numerical modeling findings. To gain insight into the general applicability of this method to other First, the impact of separately varying the pool sizes of glutamate, aspartate, and citrate over broad ranges while TCA cycle flux was held constant on glutamate lAt50 and on KT was calculated from Equation 4. It was assumed that pool sizes below 0.5 gmol/g wet wt were not quantified by`3C NMR and thus neglected in calculation of KT, as in the earlier experiments. Figure 10 shows that at a constant cycle flux the glutamate lAt50 increases as expected with increases in the glutamate, aspartate, and citrate pools and importantly demonstrates that calculated KT is relatively unchanged by these large changes in pool sizes. The mean KT was 1.01±0.01 ,umol/min/g wet wt for this range of glutamate, aspartate, and citrate pools, which extend beyond those previously measured in hearts exposed to substrates other than acetate. 2, 4, 7, 35 Second, the potential impact of changes in the smaller pools of oxaloacetate, 2-oxoglutarate, succinate, and malate on KT was assessed in a similar manner. The extent to which these smaller pools, which typically cannot be quantified by 13C NMR and hence are neglected in calculation of KT, are changed by conditions of altered substrate or oxygen availability has been less well studied. Therefore, an extreme example of a fourfold increase in the pool sizes of all of these intermediates was chosen. Such changes considerably exceed, for example, the roughly threefold increases in succinate and malate, unchanged fumarate, and 80% decrease in 2-oxoglutarate reported after 20 minutes of total ischemia in glucose-perfused rat hearts.13 Figure 11 presents the time course '3C-enrichment curves for the glutamate C-4 and C-2 isotopomers derived from the model for the control (solid line) and increased pool size (dotted line) conditions and demonstrates that for both Compartmentation and`3C Labeling Kinetics Although TCA cycle activity occurs in mitochondria, a significant fraction of myocardial glutamate is located in the cytoplasm. To investigate whether the time course of glutamate 13C enrichment reflects that of mitochondrial TCA cycle intermediates, additional experiments were performed. Because rat heart mitochondria, unlike liver or adipocyte mitochondria, are relatively impermeable to citrate (R.G. Hansford, personal communication),24-26 we compared the time course of 13C appearance in the glutamate isotopomers with that in citrate derived from the same "turns" of the TCA cycle. Because previous work has shown that pyruvate perfusion increases cellular citrate concentrations approximately 20-fold,27 unlabeled 0.8 mM pyruvate was added to the perfusate in this series of hearts (n =5) to increase citrate 13C resonances and enhance quantification. Figure 12 presents an expanded region of a "C difference spectrum from an intact heart acquired 25 minutes after perfusion with unlabeled 0.8 mM pyruvate and 5 mM [2-'3C]acetate. In comparison to hearts perfused with acetate alone (Figure 3 ), prominent peaks of citrate C-4 and citrate C-2 at 45 ppm and citrate C-3 at 76 ppm are readily identified.37 Note that the glutamate resonances are much less prominent than those in hearts perfused solely with FIGURE 11 . The numerical model-generated time course of glutamate isotopomer enrichment for the extremes of cardiac contractile performance studied. The effect on glutamate`3C enrichment of a simultaneous fourfold increase in the oxaloacetate, 2-oxoglutarate, succinate, and malate pool sizes (dotted lines) over that calculated using pool sizes reported in acetate-perfused hearts (solid lines) is a subtle delay in each isotopomer enrichment. This increase in pool sizes altered the calculated total tricarboxylic acid cycle flux parameter by only 5-7%. acetate (Figure 3 ) because of both the decrease in "C enrichment of acetyl-CoA entering the citric acid cycle and the previously reported smaller glutamate pool size during unlabeled pyruvate supplementation. 27 Because of the symmetry of the citrate molecule, citrate C-4 and C-2 cannot be resolved. Hence the citrate C-3 resonance, which is well resolved, was quantified and the enrichment time course compared with that of the equivalent glutamate isotopomer (C-2 or C-3), which is also enriched in the later "turns" of the cycle. Figure 13 displays citrate C-3 and glutamate C-2 enrichment versus time after [2-13C] acetate was substituted for the unenriched form. The time courses of 13C enrichment of citrate C-3 and glutamate C-2 are similar and not statistically different. Because rat heart mitochondria are relatively impermeable to citrate, these findings indicate that, within the limits of the signal-to-noise ratio and temporal resolution of these experiments, the time course of 13C glutamate enrichment is similar to that of citric acid cycle intermediates confined to the mitochondria and further suggest that quantification of myocardial glutamate 13C enrichment provides valid information regarding citric acid cycle kinetics. The method proposed in the present study for estimating of TCA cycle flux is a simplified empirical 0.0 approach to the many reactions that make up the 0 5 10 15 20 25 30 TCA cycle. This method can be used in conjunction TIME (minutes) with computer modeling and offers some unique advantages. The computer modeling of the TCA FIGURE 13 . The time course of 13Cenchment in gltamate cycle by Chance et a17 as well as the mathematical C-2 and citrate C-3 expressed as micromoles per gram wet model presented in the "Appendix" requires detailed weight versus time from substitution of 5 mM [2-'3C]acetate information about metabolite pool sizes for each for the unenriched form in thepresence of 0.8 mMpyruvate in modeled reaction. Such information can be obtained five intact beating hearts. The similar time course of enrich-only from chemical analysis of tissue extracts or from ment of these two moieties, one predominantly mitochondrial published literature. While the latter is valid if experand the other significantly cytosolic, suggests that 13C move-imental conditions exactly mimic those in previously ment across the mitochondrial membrane and transamination published work, the former requires tissue destrucis rapid relative to citric acid flux. tion, thus precluding serial studies in a single organ as well as in vivo studies. For these reasons, there are wide range of contractile function under different considerable potential advantages of indexing TCA experimental conditions. cycle flux by 13C NMR measures alone. The parameters Most previous investigations with labeled subcan be obtained nondestructively and rely minimally, or strates to index oxidative metabolic flux have relied not at all, on results from prior studies. In addition, the on the detection of tissue or effluent radioactivity presented method can be more readily used to quantiafter administration of radiolabeled substrates.238 In tatively compare results among different 13C NMR a recent report, the rate of the initial rapid phase of studies since the TCA cycle flux indexes are experimentissue and effluent radioactivity from isolated rat tally determined and not model dependent. hearts correlated with oxygen consumption after A theoretical limitation of the proposed construct bolus administration of tracer [1-'4C]acetate.3 As in is that changes in TCA cycle intermediate pool sizes the current investigation, several different levels of that are not detected by NMR could change the time cardiac contractile performance were studied, a TCA course of 13C enrichment in glutamate C-2 and C-3 cycle flux parameter but not absolute TCA cycle flux relative to that of glutamate C-4 and thereby alter KT was calculated, and the results correlated with oxy-in the presence of an unchanged TCA cycle flux. The gen consumption. Like all radioisotope studies, howstrong correlation of derived TCA cycle flux paramever, identification of the specific metabolites con-eters with oxygen consumption and contractile intaining the`4C radioactivity could not be determined dexes indicates that either the pool sizes of TCA nondestructively. Hence, the precise causes of the cycle intermediates not detected by 13C NMR do not poor correlation with oxygen consumption when non-vary significantly over the range of developed prestracer acetate concentrations were used and the sures studied at steady state or, if they do, that such mechanism of the second kinetic component for late differences are not of sufficient magnitude to signif-'4C washout could only be inferred. icantly alter the KT. Moreover, the results of numer-This proposal uses 13C NMR spectroscopy, which ical modeling of the TCA cycle and 13C glutamate can quantify on a continuous and nondestructive isotopomer enrichment ( Figures 10 and 11 and "Apbasis the time course of appearance of labeled car-pendix") suggest that even marked fourfold simultabon nuclei within various intracellular metabolites neous increases in the oxaloacetate, 2-oxoglutarate, and even in specific positions within a given metab-succinate, and malate pools over published values7 in olite. A detailed mathematical model of TCA cycle the absence of altered cycle flux would change KT by flux with "C NMR data has been reported previously less than 7%. Larger increases in these pools are for extracts from isolated hearts in which the citric unlikely to occur physiologically but if present would acid cycle reactions were mathematically modeled probably permit NMR detection of the metabolite and the solutions to the corresponding 200 differenpools of succinate and malate that could then be used tial equations obtained using FACSIMILE software.7 in the calculation of KT. Thus, the total TCA cycle Some distinct advantages of that method include the flux parameter, KT, is relatively insensitive to changes absolute estimation of TCA cycle flux as well as the in pools not detected by 13C NMR. The modeling aspartate aminotransferase exchange and acetyl-CoA data also support the general applicability of the formation rates. In addition, that model provides the proposed empiric method of indexing TCA cycle flux useful ability to mathematically alter metabolic pa-by KT beyond the experimental conditions studied.
Discussion
Another potential limitation is that unlabeled anaplerotic flux could affect the time course of glutamate C-2 or C-3 enrichment but not C-4 and thus impact on calculated KT independent of the steady-state acetyl-CoA-derived TCA cycle flux. Under nearly all physiological conditions the contribution of anaplerotic flux relative to acetyl-CoA-derived flux is relatively small; therefore, one would not anticipate that physiological anaplerosis would significantly alter these 13C estimates of TCA cycle flux beyond the inherent uncertainty in the constituent measurements.
Acetate was chosen as the`3C-enriched substrate for these studies since it enters the TCA cycle directly via the citrate synthase reaction as acetyl-CoA. Acetate has been reported to increase myocardial oxygen consumption and TCA cycle flux in hearts previously perfused with glucose.2 Unequal flux rates through different spans of the cycle were observed in those experiments moments after the increase in flux. Rapid attainment of steady-state occurred, however, and flux through the different spans equalized, as assumed in our studies. The methods presented here could be applied to other substrates that enter the TCA cycle as acetyl-CoA. For instance, the individual t50 for each glutamate isotopomer obtained using [1-`3C]glucose substrate would be additionally dependent on glucose uptake, glycolytic metabolism, and the pyruvate dehydrogenase reaction. Nevertheless, the difference in the time courses of C-4 and C-2 glutamate enrichment, the glutamate lAt50, would not be affected by these reactions and would depend solely on TCA cycle metabolism. In a previous report, we described [1-1'3C]glucose metabolism during graded reductions in coronary flow in isolated rat hearts.11 A reduction of coronary flow from 15 to 5 ml/min resulted in reduced [4-13C]glutamate levels (from 1.5 to 1.0 gumol/g wet wt) and increased the t50 for glutamate C-4 (from 5 to 12 minutes) and for glutamate C-2 (from 9 to 17 minutes). With the current construct, reduction of flow from 15 to 5 ml/min in [1-'3C]glucose-perfused hearts resulted in a 47% reduction in calculated KT (from 0.83 ,umol/g wet wt at 15 ml/min to 0.44 ,gmol/g wet wt at 5 ml/min), which closely paralleled the 49% reduction in contractile function.
Although subcellular compartmentation of many metabolic reactions has long been recognized, most quantitative approaches to TCA cycle flux have not addressed the potential impact of bidirectional carbon transport between mitochondrial and cytoplasmic locations.2,7 Because 13C movement from the mitochondria to the cytoplasm is crucial for 13C NMR quantification of TCA cycle flux by sequential glutamate exchange, the similar time course of 13C appearance in citrate C-3 and glutamate C-2 (Figure 13 ), within the limits of the signal-to-noise ratio and temporal resolution of these experiments, suggests that the kinetics of 13C appearance in predominantly mitochondrial and cytoplasmic pools is comparable and that transaminase activity is rapid relative to that of net TCA cycle flux.
The application of this method of indexing TCA cycle flux by 13C NMR to in vivo studies remains untested but may be possible with recently described spatially localized proton-decoupled`3C NMR cardiac techniques.8 Inherent uncertainties in in vivo studies of quantification of the time from peripheral injection of tracer to time of target tissue delivery are due to many factors that affect delivery and blood flow but should not be problematic with this approach, which primarily depends on the difference in time between sequential glutamate isotopomer enrichment. The major hurdles to in vivo application of this method will be the temporal resolution for quantification of the glutamate At50 and the resolution of the glutamate C-4 carbon-carbon splitting for quantification of FEa. The combined use of this approach with spatially localized NMR spectroscopic techniques may permit the assessment of regional myocardial TCA cycle flux and, therefore, of approximating regional oxygen consumption.
In summary, a simple approach to index TCA cycle flux in intact, isolated perfused hearts has been presented that uses only`3C NMR data, namely, the time difference in enrichment of glutamate isotopomers derived from sequential turns of the citric acid cycle, the 13C NMR-detectable metabolite pool sizes, and the fraction of acetyl-CoA that is 13C enriched entering the cycle. The validity of the approach was demonstrated by a strong correlation with myocardial oxygen consumption over a wide range of cardiac contractile function and extrapolation to a near-zero intercept when predicted oxygen consumption ceased in two separate experiments with different substrate availability. The general applicability of the approach is suggested by mathematical modeling findings that indicate that KT is relatively independent of marked differences in TCA cycle pool sizes. In addition, the similar time course of`3C enrichment in predominantly mitochondrial and cytosolic metabolites provides further evidence of the ability of these techniques to index mitochondrial citric acid cycle flux in the intact heart.
Appendix
This empirical method has proposed that citric acid cycle activity can be indexed by the time difference between the labeling of the C-4 and C-2 glutamate isotopomers (the glutamate At50). It is important to note, however, that changes in intermediate pool sizes, independent of any change in citric acid cycle activity, may influence the delta variable. A numerical model of the citric acid cycle was developed to assess the impact of changes in the pool sizes of various intermediates on the time course of glutamate isotopomer`3C enrichment and on the calculated total cycle flux parameter, KT, at a given cycle flux.
The dynamics of`3C labeling of citric acid cycle intermediates was computed using a model derived from the analysis of Chance et al.7 This analysis is based on a simplified scheme of the cycle containing citrate, a-ketoglutarate, succinate, malate, and oxaloacetate, connected by effectively irreversible reactions and coupled to pools of glutamate and aspartate by way of the alanine aminotransferase and aspartate aminotransferase reactions.
The full model, as analyzed by Chance et al, requires 176 differential equations for the various possible species labeled (or unlabeled) at all possible positions. Since only the total labeling of carbons 2 and 4 in glutamate is required for comparison with our data, the full model is not needed. Because of the symmetry resulting from the isotope independence of reaction rates, the equations may be summed over intermediates labeled at a common position to obtain 17 differential equations that describe the evolution of the fractional labeling of individual carbon positions. To demonstrate this algebraically is extremely tedious, but it may be understood intuitively by considering the possible contributions to the rate of change of the fractional labeling of the "pool" representing a particular carbon on a particular intermediate. Because the reaction scheme determines unambiguously the possible sources of this carbon, the fractional labeling can increase by addition of labeled carbon from one of these source pools and decrease by exit of carbon along the reaction path Here CI, K, S, M, 0, G, and A stand for citrate, a-ketoglutarate (2-oxoglutarate), succinate, malate, oxaloacetate, glutamate, and aspartate, respectively. K4, for example, is the fractional labeling of carbon 4 on a-ketoglutarate (using the numbering scheme of Chance et a17), and PCI, PK, PS, PM, PO, PG, and PA are the absolute total pool sizes of the corresponding intermediates. F is the citric acid cycle flux, and FA and FAL are the exchange fluxes of aspartate aminotransferase and alanine aminotransferase, respectively. AC is the fractional labeling of (carbon 2 of) acetyl-CoA (termed FEa in the text), and anaplerosis is represented by exchange of malate with an infinite unlabeled pool at a flux rate FPxF, where FP is the dimensionless fractional rate of anaplerosis. used, however, since the calculated fractional labelings are dimensionless. The pool sizes of glutamate and aspartate were measured; other pool sizes were taken from the literature but were shown to have minimal effect (over a fourfold range) on the time course of glutamate labeling (see Figures 10 and  11 ). The transaminase fluxes were taken as the mean values measured by Chance et a17 but could equally well have been computed from the pool sizes and assumed rate constants. The citric acid cycle flux F and fractional anaplerotic flux FP were determined by fitting the model to the G4 and G2
data measured from the hearts by using a Marquardt-Levenberg iterative least-squares fitting algorithm ( Figure Al) . All model computations were performed using the modeling language MLAB (Civilized Software, Bethesda, Md.).
